Status:
COMPLETED
Non-interventional Observational Study of Helical Tomotherapy for Oligometastatic Colorectal Cancer
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Colon Cancer
Rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Patients with oligometastatic colorectal cancer (5 metastases or less) receive a combination of systemic treatment and often local treatment, such as surgery, radiofrequency ablation and more recently...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with (residual) oligometastatic CRC: ≤ 5 mets
- Primary tumor treated with curative intention (surgery, radiotherapy, chemoradiotherapy)
- Functional liver volume \> 1000cc if livermets, lung DLCO \> 30% if lungmets.
- No Child B or C liver cirrhosis
- No contra-indications for radiation of all metastatic CRC (= no violation of constraints of organs at risk (OAR))
- No mets from another carcinoma
- Age \> 18 years
- WHO-PS ≤ 2
Exclusion
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00807313
Start Date
December 1 2008
End Date
November 30 2020
Last Update
December 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Brussel, Vrije Universiteit Brussel, dienst Radiotherapie
Brussels, Belgium, 1090